Wang, Bo published the artcileMechanisms and progress of parecoxib sodium, Product Details of C19H17N2NaO4S, the publication is Hainan Yixue (2014), 25(23), 3496-3499, database is CAplus.
A review. Parecoxib sodium, a novel COX-2 specific inhibitor, is now widely used in clin. prevention and treatment of moderate to severe pain. Recent studies have suggested that parecoxib sodium exerts not only an analgesic effect but also some non-analgesic effects. Parecoxib sodium reduces cerebral ischemic neuronal damage, protects or deteriorates ischemic organs, produces anti-tumor effects, as well as against angiogenesis effect. The study on the non-analgesic effects of parecoxib sodium provides theor. basis for expanding its clin. applications. In this paper, we reviewed the progress in the functional roles of parecoxib sodium and its underlying mechanisms.
Hainan Yixue published new progress about 198470-85-8. 198470-85-8 belongs to isoxazole, auxiliary class Immunology/Inflammation,COX, name is Sodium ((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)(propionyl)amide, and the molecular formula is C24H29N5O3, Product Details of C19H17N2NaO4S.
Referemce:
https://en.wikipedia.org/wiki/Isoxazole,
Isoxazole | C3H3NO – PubChem